Expression of Fcγ and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis

Rheumatology

Volumn 43, Issue 5, 2004, Pages 547-554

  Hepburn, A L ^a   Mason, J C ^a   Davies, K A ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Complement receptor; Fc receptor; Monocyte; Rheumatoid arthritis; SLE

Indexed keywords

AZATHIOPRINE; CD11B ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT RECEPTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; DNA ANTIBODY; FC RECEPTOR; GOLD; HYDROXYCHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; LEFLUNOMIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MOLECULAR INTERACTION; MONOCYTE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VENOUS BLOOD; BLOOD; DRUG EFFECT; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; PREDNISOLONE; RECEPTORS, COMPLEMENT; RECEPTORS, IGG; SEVERITY OF ILLNESS INDEX;

EID: 3042806873     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh112     Document Type: Article

References (48)

1. Davies KA. Immune complexes and autoimmunity. In: Lahita RG, Chiorazzi N, Reeves WH, eds. Textbook of the autoimmune diseases. Philadelphia: Lippincott, Williams & Wilkins, 2000:137-51.
2. Schifferli JA, Taylor RP. Physiological and pathological aspects of circulating immune complexes. Kidney Int 1989;35:993-1003.
3. Shirakawa F, Yamashita U, Suzuki H. Reduced function of HLA-DR positive monocytes in patients with systemic lupus erythematosus. J Clin Immunol 1985;5:396-403.
4. Salmon JE, Kimberly RP, Gibofsky A, Fonito M. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalisation. J Immunol 1984;133:2525-31.
5. Nockher WA, Wigand R, Schoeppe W, Scherberich JE. Elevated levels of soluble CD14 in patients with systemic lupus erythematosus. Clin Exp Immunol 1994;96:15-9.
6. Funauchi M, Ohno M, Minoda M, Horiuchi A. Abnormal expression of intercellular adhesion molecule-1 on peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Clin Lab Immunol 1993;40:115-24.
7. Tas SW, Fossati-Jimack L, Davies K, Botto M, Walport MJ. Adhesion defect and impaired uptake of apoptotic cells in macrophages from SLE patients. Rheumatology 2002;41(Suppl. 1):29.
8. Clarkson SB, Ory PA. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J Exp Med 1988;167: 531-7.
9. van de Winkel JG, Anderson CL. Biology of human immunoglobulin Fc receptors. J Leuk Biol 1991;49:511-524.
10. Pricop L, Redecha P, Teillaud JL et al. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol 2001;166:531-7.
11. Szucs G, Kavai M, Suranyi P, Kiss E, Csipo I, Szegedi G. Correlations of monocyte phagocytic receptor expressions with serum immune complex level in systemic lupus erythematosus. Scand J Immunol 1994;40:481-4.
12. Seres T, Csipo I, Kiss E, Szegedi G, Kavai M. Correlation of Fcγ receptor expression of monocytes with clearance function by macrophages in systemic lupus erythematosus. Scand J Immunol 1998;48:307-11.
13. Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lowered complement level. Clin Exp Immunol 1970;6:689-706.
14. Mannik M. Rheumatoid factors in the pathogenesis of rheumatoid arthritis. J Rheumatol 1992;32(Suppl.):46-9.
15. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989;74:2527-34.
16. Cairns AP, Crockard AD, Bell AL. The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheum Int 2002;21:189-92.
17. Kawanaka N, Yamamura M, Aita T et al. CD14+ CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002;46:2578-86.
18. Blom AB, Radstake TR, Holthuysen AE et al. Increased expression of Fcγ receptors II and III on macrophages or rheumatoid arthritis patients results in higher production of tumour necrosis factor α and matrix metalloproteinase. Arthritis Rheum 2003;48:1002-14.
19. Shinohara S, Hirohata S, Inoue T, Ito K. Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritis. J Rheumatol 1992;19:211-5.
20. Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Monocyte activation in rheumatoid arthritis: increased integrin, Fcγ and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999;115:554-60.
21. Wahl SM, Allen JB, Welch GR, Wong HL. Transforming growth factor-β in synovial fluids modulates FcγRIII (CD16) expression on mononuclear phagocytes. J Immunol 1992;148:485-90.
22. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
23. Bombardier C, Galdman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Villaverde V, Balsa A, Cantalejo M et al. Activity indices in rheumatoid arthritis. J Rheumatol 2000;27:2576-81.
26. van de Winkel JG, Anderson CL. CD32 cluster workshop report. In: Schlossman SF, Boumsell L, Golks W et al., eds. Leucocyte typing V. White cell differentiation antigens. Oxford: Oxford University Press 1995:823-6.
27. Vely F, Gruel N, Moncuit J et al. A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assays. Hybridoma 1997;16:519-28.
28. Wijngaarden S, van Roon JA, Bijlsma JW, van de Winkel JG, Lafeber FP. Fcγ receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology 2003;42:681-8.
29. Masuda M, Morimoto T, Kobatake S et al. Measurement of soluble Fcγ receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clin Exp Immunol 2003;132:477-84.
30. Levy PC, Utell MJ, Fleit HB et al. Characterization of human alveolar macrophages Fc receptor III. A transmembrane glycoprotein that is shed under in vitro culture conditions. Am J Resp Cell Mol Biol 1991;5:307-14.
31. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumour necrosis factor α production by adhered human monocytes: a key role for Fcγ receptor type IIIA in rheumatoid arthritis. Arthritis Rheum 2000;43:608-16.
32. Ross GD, Yount WJ, Walport MJ et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol 1985;135:2005-14.
33. Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985;59:547-54.
34. Yen JH, Liu HW, Lin SF, Chen TP. Erythrocyte complement receptor type 1 in non-SLE rheumatic diseases. Rheumatol Int 1990;10:71-3.
35. Kumar A, Malaviya AN, Srivastava LM. Lowered expression of C3b receptor (CR1) on erythrocytes from rheumatoid arthritis patients. Immunobiology 1994;191:9-20.
36. McCarthy D, Taylor MJ, Bernhagen J, Perry JD, Hamblin AS. Leucocyte integrin and CR1 expression on peripheral blood leucocytes of patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:307-12.
37. Cairns AP, Crockard AD, Bell AL. Complement receptor expression of relevance to apoptotic cell clearance in SLE. Rheumatology 2003;42:487-8.
38. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression and cytokine release. Clin Exp Immunol 1996;106:13-9.
39. Prieto J, Eklund A, Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol 1994;156:191-211.
40. Boyd AW, Dunn SM, Fecondo JV, Culvenor JG, Duhrsen U, Burns GF, Wawryk SO. Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohaematopoietic differentiation. Blood 1989;73:1896-903.
41. Myers CL, Wertheimer SJ, Schembri King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-α, IL-1β and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992;263(4 Pt 1):C767-772.
42. Egerer K, Feist E, Rohr U, Pruss A, Burmester GR, Dorner T. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000;9:614-21.
43. Nockher WA, Scherberich JE. Expression and release of lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 1997;158:1345-52.
44. Steinbach F, Henke F, Krause B, Thiele B, Burmester GR, Hiepe F. Monocytes from patients with systemic lupus erythematosus are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 2000;59:283-8.
45. Fingerle-Rowson G, Angstwurm. M, Andreesen R, Ziegler-Heitbrock HW. Selective depletion of CD14+CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 1998;112:501-6.
46. Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000;59:243-51.
47. Mitamura K, Kang H, Tomita Y, Hashimoto H, Sawada S, Horie T. Impaired tumour necrosis-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus. Clin Exp Immunol 1991;85:386-91.
48. Limb GA, Hamblin AS, Wolstencroft RA, Dumonde DC. Rapid cytokine up-regulation of integrins, complement receptor 1, HLA-DR on monocytes but not on lymphocytes. Immunology 1992;77:88-94.